Skip to main content
Clinical Trials/EUCTR2008-001637-10-FI
EUCTR2008-001637-10-FIActive, not recruitingNot Applicable

Acute heart failure in acute coronary syndrome: Double blind comparison of levosimendan and placebo - LEVI´S

HUCH, Division of Cardiology0 sitesStarted: June 23, 2008Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Inclusion criteria
  • A. Acute coronary syndrome
  • - unstable angina, NSTEMI (non ST-elevation myocardial infarction), or STEMI (ST-elevation myocardial infarction) according to current guidelines.
  • B. symptoms and signs of heart failure:
  • 1. hypoxia and dyspnea at rest due to decompensated CHFo
  • 2. increased filling pressure (pulmonary artery wedge pressure (PCWP) > 20 mmHg) by Swan-gantz catheter or by echocardiographic estimation.
  • C. Written informed consent by patient or a close relative
  • D. Age >18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Exclusion criteria
  • Cardiogenic shock
  • Systolic arterial pressure below 100 mmHg despite of adequate fluid balance
  • Heart rate > 120 bpm
  • Sustained ventricular tachycardia not related to early perfusion
  • Use of intravenous ß-adrenergic agonists during admission within 24 hours before screening , and intravenous PDE inhibitors (e.g., milrinone, amrinone) within 2 days.
  • Vasopressor treatment
  • Pneumonia or sepsis
  • ARDS; hypoxemia due to severe COPD
  • Heart failure due to restrictive or hypertrophic cardiomyopathy or to uncorrected stenotic valvular disease
  • Planned surgery
  • Known hypersensitivity to study medication
  • Known history of Torsades de pointes
  • hypo- or hyperkalemia
  • significant renal or hepatic failure
  • intra aortic balloon pump or left ventricular assist device

Investigators

Sponsor
HUCH, Division of Cardiology

Similar Trials